Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-25-000024 General Corporate
Debt relative to revenue 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
34.75% · OPTIONAL · VALID
Capex intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.97% · OPTIONAL · VALID
Operating cash generation 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.01% · OPTIONAL · VALID
Revenue growth 25th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-1.06% · CORE · VALID
Inventory pressure 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
17.86% · OPTIONAL · VALID
Operating margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-29.66% · CORE · VALID
R&D intensity 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.17% · OPTIONAL · VALID
SBC intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.87% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 145.80%
Current 34.75%
Delta -111.05% Capex Intensity Decreased
Previous 7.68%
Current 6.97%
Delta -0.71% Cash Generation Decreased
Previous 18.49%
Current 9.01%
Delta -9.48% Growth Increased
Previous -2.66%
Current -1.06%
Delta 1.60% Inventory Pressure Decreased
Previous 65.79%
Current 17.86%
Delta -47.93% Profitability Decreased
Previous 3.33%
Current -29.66%
Delta -32.98% R And D Intensity Increased
Previous 2.17%
Current 2.17%
Delta 0.00% Sbc Intensity Increased
Previous 0.77%
Current 0.87%
Delta 0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.